Primary Peritoneal Carcinoma: Symptoms, Causes, Diagnosis, and Treatment

~Introduction

Primary Peritoneal Carcinoma (PPC) is a rare and aggressive cancer that develops in the peritoneum, the thin layer of tissue lining the inside of the abdomen and covering many abdominal organs. Although it originates in the peritoneal lining, this cancer closely resembles epithelial ovarian cancer in terms of symptoms, microscopic appearance, and treatment.

Primary Peritoneal Carcinoma can affect both women and men, but it is far more common in women. Interestingly, some women develop this cancer even after their ovaries have been removed, which highlights the close biological relationship between the peritoneum and ovarian tissue.

Because early symptoms are often vague and easily mistaken for digestive problems, PPC is frequently diagnosed at an advanced stage. Early recognition and proper treatment can improve patient outcomes.

This comprehensive article explains Primary Peritoneal Carcinoma, including its causes, symptoms, risk factors, diagnosis, staging, treatment options, and prognosis.

~What is Primary Peritoneal Carcinoma?

Primary Peritoneal Carcinoma is a malignancy that originates in the peritoneal lining of the abdomen. The peritoneum is a protective membrane that supports abdominal organs such as the stomach, intestines, liver, and spleen.

The peritoneum produces fluid that allows organs to move smoothly during digestion. In PPC, the cells of this lining become cancerous and begin to grow uncontrollably, forming tumors within the abdominal cavity.

Although PPC develops in the peritoneum rather than the ovaries, it behaves very similarly to high-grade serous ovarian cancer. Under a microscope, the cancer cells look almost identical.

Doctors often diagnose PPC when:

• Cancer is found throughout the abdomen

• The ovaries appear normal or only minimally involved

• The tumor originates primarily in the peritoneal lining

~Causes of Primary Peritoneal Carcinoma

The exact cause of Primary Peritoneal Carcinoma remains unknown. However, researchers believe it develops due to genetic mutations in the cells of the peritoneum.

Because the peritoneum and ovarian surface originate from the same embryonic tissue, they share similar biological characteristics. This explains why PPC behaves similarly to ovarian cancer.

Several factors may increase the risk of developing PPC.

Genetic Mutations

Mutations in certain genes can increase the likelihood of developing this cancer. The most significant genetic factors include:

• BRCA1 gene mutation

• BRCA2 gene mutation

These genes normally help repair damaged DNA. When they are mutated, cells may grow uncontrollably, leading to cancer.

Women who carry BRCA mutations have a higher risk of developing both ovarian cancer and Primary Peritoneal Carcinoma.

Age

Primary Peritoneal Carcinoma is most commonly diagnosed in women over the age of 60. The risk increases with age.

Hormonal Factors

Some hormonal influences may play a role in the development of PPC, though research is still ongoing.

Family History

People with a strong family history of ovarian, breast, or peritoneal cancer may have an increased risk of developing PPC.

~Symptoms of Primary Peritoneal Carcinoma

Symptoms of PPC often develop gradually and may resemble common gastrointestinal or abdominal disorders. Because of this, the disease may remain undetected for a long time.

Common symptoms include:

Abdominal Bloating

Persistent bloating is one of the most common symptoms. It may occur due to fluid buildup in the abdomen.

Abdominal Pain

Patients may experience ongoing pain or discomfort in the abdomen or pelvic region.

Ascites (Fluid Accumulation)

Cancer can cause fluid to accumulate in the abdomen, leading to swelling and discomfort.

Changes in Bowel Habits

Some patients experience:

• Constipation

• Diarrhea

• Difficulty passing stool

Loss of Appetite

Many patients report feeling full quickly or losing interest in food.

Unexplained Weight Loss

Cancer-related metabolic changes may cause unintended weight loss.

Fatigue

Persistent tiredness and weakness are common symptoms.

Nausea or Indigestion

Digestive disturbances may occur due to pressure on abdominal organs.

Because these symptoms are nonspecific, it is important to seek medical evaluation if they persist for several weeks.

~Risk Factors

Several factors may increase the risk of developing Primary Peritoneal Carcinoma.

BRCA Gene Mutations

Individuals with BRCA1 or BRCA2 mutations face a significantly higher risk.

History of Ovarian or Breast Cancer

Patients with a personal history of these cancers may be more likely to develop PPC.

Genetic Syndromes

Certain hereditary cancer syndromes increase susceptibility.

Age and Postmenopausal Status

Most cases occur in postmenopausal women.

Family History

A strong family history of ovarian or breast cancer raises the risk.

~Diagnosis of Primary Peritoneal Carcinoma

Diagnosing PPC can be challenging because its symptoms mimic many other conditions.

Doctors typically use several diagnostic tools to confirm the disease.

Physical Examination

The doctor checks for abdominal swelling, fluid accumulation, or tenderness.

Imaging Tests

Ultrasound

Ultrasound imaging can detect fluid buildup and masses in the abdomen.

CT Scan

A CT scan provides detailed images of abdominal organs and helps detect tumors in the peritoneum.

MRI

Magnetic resonance imaging offers high-resolution images that help determine the spread of the cancer.

Blood Tests

Doctors may measure tumor markers such as:

CA-125

Elevated CA-125 levels are commonly seen in PPC and ovarian cancer, although they are not specific for diagnosis.

Paracentesis

If fluid accumulates in the abdomen, doctors may remove a sample using a needle. This procedure is called paracentesis.

The fluid is examined under a microscope to look for cancer cells.

Biopsy

A biopsy is the most definitive method for diagnosing Primary Peritoneal Carcinoma.

During this procedure, doctors remove a small tissue sample from the peritoneum and analyze it in a laboratory.

Biopsies may be performed through:

• Laparoscopy (minimally invasive surgery)

• Open surgery

~Staging of Primary Peritoneal Carcinoma

Because PPC closely resembles ovarian cancer, doctors use a similar staging system.

Stage I

Cancer is limited to the peritoneum.

Stage II

Cancer spreads to nearby pelvic organs.

Stage III

Cancer spreads throughout the abdominal cavity or to nearby lymph nodes.

Stage IV

Cancer spreads to distant organs such as the liver or lungs.

Most patients are diagnosed in Stage III or Stage IV because symptoms appear late.

~Treatment Options

Treatment for Primary Peritoneal Carcinoma usually involves a combination of therapies.

The main treatments include:

• Surgery

• Chemotherapy

• Targeted therapy

• Palliative care

Surgery

Surgery is often the first step in treating PPC. The goal is to remove as much of the tumor as possible.

This procedure is known as cytoreductive surgery or debulking surgery.

During surgery, doctors may remove:

• Visible tumors

• The omentum (fatty tissue in the abdomen)

• Sections of affected organs

The success of surgery depends on how much cancer can be removed.

Chemotherapy

Chemotherapy is a standard treatment for PPC. It uses powerful drugs to destroy cancer cells.

The most commonly used drugs include:

• Carboplatin

• Cisplatin

• Paclitaxel

Chemotherapy may be given:

• After surgery (adjuvant therapy)

• Before surgery (neoadjuvant therapy)

In some cases, chemotherapy is delivered directly into the abdominal cavity, a method called intraperitoneal chemotherapy.

Targeted Therapy

Targeted therapies focus on specific molecules that help cancer grow.

One important class of targeted drugs is PARP inhibitors, which are particularly effective for patients with BRCA mutations.

These drugs block cancer cells from repairing damaged DNA, leading to cell death.

Immunotherapy

Immunotherapy aims to boost the body's immune system to fight cancer.

Although still under research for PPC, some patients may benefit from this treatment, particularly in clinical trials.

Palliative Care

Palliative care focuses on improving quality of life rather than curing the disease.

This may include:

• Pain management

• Fluid drainage

• Nutritional support

• Psychological counseling

Palliative treatments are especially important for patients with advanced disease.

~Prognosis and Survival Rate

The prognosis of Primary Peritoneal Carcinoma varies depending on several factors, including:

• Stage at diagnosis

• Patient's overall health

• Response to treatment

• Genetic mutations

The average five-year survival rate ranges between 20% and 40%, although outcomes vary widely.

Patients who undergo successful surgery followed by chemotherapy often experience better survival outcomes.

~Prevention and Risk Reduction

There is no guaranteed way to prevent Primary Peritoneal Carcinoma. However, certain measures may help reduce the risk.

Genetic Testing

Individuals with a strong family history of cancer may benefit from genetic testing for BRCA mutations.

Preventive Surgery

Some high-risk women choose preventive removal of the ovaries and fallopian tubes. However, PPC can still develop even after this surgery.

Regular Medical Checkups

Early detection of symptoms and regular health screenings may improve outcomes.

~Living with Primary Peritoneal Carcinoma

Living with PPC can be physically and emotionally challenging. Support from healthcare professionals, family, and patient communities can help patients cope with the disease.

Lifestyle measures that may support overall health include:

• Balanced nutrition

• Regular physical activity

• Stress management

• Emotional support

Cancer support groups can provide valuable information and encouragement for patients and families.

~Future Research and Emerging Treatments

Researchers are continuously exploring new treatments for Primary Peritoneal Carcinoma.

Promising areas of research include:

Personalized Medicine

Tailoring treatment based on a patient's genetic profile.

Advanced Targeted Drugs

New therapies that target specific cancer pathways.

Immunotherapy Combinations

Combining immunotherapy with chemotherapy or targeted therapy.

Clinical trials are ongoing to evaluate these innovative approaches.

~Conclusion

Primary Peritoneal Carcinoma is a rare but serious cancer that develops in the lining of the abdominal cavity. Although it closely resembles ovarian cancer, it originates in the peritoneal tissue.

Symptoms often include abdominal bloating, pain, fluid buildup, digestive problems, and fatigue. Because these symptoms are subtle, the disease is often diagnosed at an advanced stage.

Diagnosis involves imaging tests, blood markers, and biopsy confirmation. Treatment typically includes surgery, chemotherapy, and targeted therapy.

While the prognosis can be challenging, advances in cancer research are improving treatment options and survival rates. Early detection, genetic awareness, and access to specialized medical care remain key factors in managing this disease.